Article | New England Journal of Medicine | November 18 2004

Merck's Recall of Rofecoxib: A Strategic Perspective

by Felix Oberholzer-Gee and Noorein Inamdar

Keywords: Health; Perspective; Pharmaceutical Industry;

Citation:

Oberholzer-Gee, Felix, and Noorein Inamdar. "Merck's Recall of Rofecoxib: A Strategic Perspective." New England Journal of Medicine 351, no. 21 (November 18 2004): 2147–2149.